Related Experiment Video
Updated: Aug 11, 2026

Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping
Published on: February 22, 2018
Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis
1Department of Biological Sciences, University of Pittsburgh, PA 15260, USA.
Insights
This study reveals how ion channels influence cardiac arrhythmias. Potassium channel blockers effectively control reentry, while sodium and calcium channel blockers can worsen arrhythmias by altering the critical ring size.
Area of Science:
- Computational biology
- Cardiac electrophysiology
- Pharmacology
Background:
- Cardiac arrhythmias are a major cause of mortality.
- Understanding the role of ion channels in cardiac electrophysiology is crucial for developing effective antiarrhythmic therapies.
Purpose of the Study:
- To elucidate the effect of key ion channels on cardiac arrhythmias using bifurcation analysis.
- To explain the efficacy of antiarrhythmic drugs in controlling arrhythmias.
- To investigate the impact of ion channel blockers on critical ring size and reentry dynamics.
Main Methods:
- Bifurcation analysis of a cardiac tissue model.
- Modeling ventricular action potential with fast sodium, slow calcium, and background potassium channels.
- Simulating a ring structure to analyze reentrant arrhythmias.
Main Results:
- A critical ring size (CRS) was identified, influencing action potential amplitude and conduction velocity (CV) stability.
- Sodium channel blockers decrease CRS, promoting reentry (proarrhythmia).
- Calcium channel blockers shorten CRS, also exerting a proarrhythmic effect.
- Potassium channel blockers lengthen CRS, controlling reentry, but near-complete blockade can cause ectopic foci.
Conclusions:
- Key ion channels significantly affect cardiac reentry dynamics and critical loop length.
- The study provides a theoretical basis for the proarrhythmic effects of certain antiarrhythmic drugs.
- Bifurcation analysis offers insights into drug-induced arrhythmias and guides therapeutic strategies.
Abstract:
This study employs a bifurcation analysis approach to elucidate the effect of the key ion channels on cardiac arrhythmias and thereby explain the efficacy of antiarrhythmic drugs in controlling arrhythmias. The model used for the analysis contains the key ion channels involved in the ventricular action potential--fast sodium, slow calcium, and background potassium channels. The cardiac tissue is modeled by a ring structure. The bifurcation diagram reveals that at a certain ring size, the amplitude of the action potential suddenly shrinks and the conduction velocity (CV) becomes unstable. Instability in CV leads to termination of reentrant arrhythmias. This ring size (ie, the critical ring size [CRS]) depends of the type of channel blocker. Blocking of the sodium channel leads to a decrease in the CRS, which in turn enhances stable reentry (proarrhythmia). Although calcium channel blockers do not alter the CV, they can exert the proarrhythmic effect by drastically shortening the CRS. The potassium channel blockers, on the other hand, are effective in controlling reentry in ventricular tissues by lengthening the CRS. Near blocking of the potassium channel, however, brings about another type of arrhythmia--the formation of ectopic foci. In the neighborhood of the CRS, the cycle length oscillates with an interesting pattern that depends on ring size and drug type. Although a critical reentrant loop length for stable reentrant excitation has been investigated for a long time, this study is the first demonstration of how the key ion channels in the plasma membrane affect the loop length. Furthermore, the analysis approach provides a theoretical basis for the increased mortality associated with class I drug use in the Cardiac Arrhythmia Suppression Trial Team.
More Related Videos
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

